SangJoon Mo
Impact in
- Biotechnology top 5%
- Microbial Metabolism and Applications
- Pharmacology top 5%
- Microbial Natural Products and Biosynthesis
- Pharmacological Effects of Natural Compounds
Papers in
-
- Biochemical and Molecular Research 6
- Signaling Pathways in Disease 5
- Genomics and Phylogenetic Studies 5
- Enzyme Catalysis and Immobilization 3
- Pharmacology 13
- Microbial Natural Products and Biosynthesis 12
- Pharmacological Effects of Natural Compounds 3
- Co-authors
- Yeo Joon Yoon (5 shared papers)Young Ji Yoo (3 shared papers)Kevin A. Reynolds (3 shared papers)Joo‐Won Suh (5 shared papers)Je Won Park (2 shared papers)Sung‐Kwon Lee (4 shared papers)Chung‐Hun Oh (2 shared papers)Beom Seok Kim (1 shared paper)
- Journals
- Biotechnology Letters (2 papers)Journal of Industrial Microbiology & Biotechnology (1 paper)Canadian Journal of Microbiology (1 paper)Frontiers in Immunology (1 paper)Anticancer Research (1 paper)
- Partner nations
- South KoreaUnited StatesUnited Kingdom
In The Last Decade
SangJoon Mo
29 papers receiving 452 citations
Peers
Comparison fields: 5 of 66
- Biotechnology 133
- Pharmacology 237
- Transplantation 18
- Pharmacology 45
- Molecular Biology 300
Countries citing papers authored by SangJoon Mo
This map shows the geographic impact of SangJoon Mo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by SangJoon Mo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites SangJoon Mo more than expected).
Fields of papers citing papers by SangJoon Mo
This network shows the impact of papers produced by SangJoon Mo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by SangJoon Mo. The network helps show where SangJoon Mo may publish in the future.
Co-authors
The 25 scholars most cited alongside SangJoon Mo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 78 | |
| 2 | 2009 | 71 | |
| 3 | 2012 | 44 | |
| 4 | 2012 | 40 | |
| 5 | 2005 | 29 | |
| 6 | 2015 | 23 | |
| 7 | 2008 | 18 | |
| 8 | 2009 | 17 | |
| 9 | 2009 | 16 | |
| 10 | 2019 | 16 | |
| 11 | 2013 | 14 | |
| 12 | 2016 | 14 | |
| 13 | 2019 | 13 | |
| 14 | 2021 | 13 | |
| 15 | 2012 | 8 | |
| 16 | 2016 | 7 | |
| 17 | 2011 | 7 | |
| 18 | 2021 | 7 | |
| 19 | 2012 | 5 | |
| 20 | 2021 | 3 |
About SangJoon Mo
SangJoon Mo is a scholar working on Molecular Biology, Pharmacology, Biotechnology, Radiology, Nuclear Medicine and Imaging and Pharmacology, having authored 31 papers that have together received 463 indexed citations. Recurring topics across this work include Microbial Natural Products and Biosynthesis (12 papers), Biochemical and Molecular Research (6 papers), Laser Applications in Dentistry and Medicine (6 papers), Signaling Pathways in Disease (5 papers), Genomics and Phylogenetic Studies (5 papers), Microbial Metabolism and Applications (5 papers), Enzyme Catalysis and Immobilization (3 papers) and Pharmacological Effects of Natural Compounds (3 papers). The work is most often cited by research in Biotechnology (133 citations), Pharmacology (237 citations), Transplantation (18 citations), Pharmacology (45 citations) and Molecular Biology (300 citations). SangJoon Mo has collaborated with scholars based in South Korea, United States and United Kingdom. Frequent co-authors include Yeo Joon Yoon, Young Ji Yoo, Kevin A. Reynolds, Joo‐Won Suh, Je Won Park, Sung‐Kwon Lee, Chung‐Hun Oh, Beom Seok Kim, Gregory L. Challis and Ying‐Yu Jin. Their work appears in journals such as Biotechnology Letters, Journal of Industrial Microbiology & Biotechnology, Canadian Journal of Microbiology, Frontiers in Immunology and Anticancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.